| 20.11.2024 16:00 | AZN | Director/PDMR Shareholding | RNS |
| 20.11.2024 09:53 | SGE, DPLM, INF | LONDON BROKER RATINGS: United Utilities raised; HSBC cuts easyJet | Alliance |
| 19.11.2024 15:47 | AZN | AstraZeneca "disappointed" as breast cancer drug blocked for NHS use | Alliance |
| 18.11.2024 12:43 | GRP, TBCG, AZN | DIRECTOR DEALINGS: AstraZeneca chair and CAB Payments director buy | Alliance |
| 18.11.2024 09:01 | AZN | TOP NEWS: AstraZeneca hails recommended EU approval of Tagrisso | Alliance |
| 15.11.2024 14:00 | AZN | Director/PDMR Shareholding | RNS |
| 15.11.2024 11:04 | SXS, AZN, TRIG | DIRECTOR DEALINGS: AstraZeneca CEO Soriot buys GBP2 million in shares | Alliance |
| 15.11.2024 10:00 | AZN | Director/PDMR Shareholding | RNS |
| 14.11.2024 09:32 | ATYM, TTG, BAB | LONDON BROKER RATINGS: Goldman Sachs raises Dr Martens to 'neutral' | Alliance |
| 13.11.2024 16:00 | AZN | Director/PDMR Shareholding | RNS |
| 13.11.2024 09:33 | FLTR, CRE, SXS | LONDON BROKER RATINGS: Deutsche Bank raises Ibstock to 'buy' | Alliance |
| 12.11.2024 19:50 | AZN | IN BRIEF: Merck trial shows Koselugo effective in treating adults | Alliance |
| 12.11.2024 08:59 | AZN | TOP NEWS: AstraZeneca lifts annual guidance despite possible forex hit | Alliance |
| 12.11.2024 07:10 | AZN | AstraZeneca invests $3.5 billion in US | RNS |
| 12.11.2024 07:05 | AZN | KOMET Phase III trial met primary endpoint | RNS |
| 12.11.2024 07:00 | AZN | 9M and Q3 2024 Results | RNS |
| 12.11.2024 07:00 | AZN | Dato-DXd new BLA submitted, NSQ BLA withdrawn | RNS |
| 11.11.2024 12:07 | AZN, AGL | Angle notes use of Parsortix system in treatment resistance study | Alliance |
| 08.11.2024 09:13 | AZN | AstraZeneca touts positive results from nasal polyp treatment study | Alliance |
| 08.11.2024 07:00 | AZN | Tezspire nasal polyps trial met primary endpoints | RNS |
| 07.11.2024 11:14 | AZN | TOP NEWS: AstraZeneca says China chief detained as under investigation | Alliance |
| 06.11.2024 09:32 | SBRE, ASC, MGAM | LONDON BROKER RATINGS: RBC raises Burberry, Deutsche cuts AstraZeneca | Alliance |
| 05.11.2024 18:39 | AZN | TOP NEWS: AstraZeneca pledges to assist in China probe as shares slide | Alliance |
| 05.11.2024 16:49 | AZN | AZN share price movement | RNS |
| 05.11.2024 14:48 | VOD, ZOO, RWI | UK earnings, trading statements calendar - next 7 days | Alliance |
| 01.11.2024 15:00 | AZN | Total Voting Rights | RNS |
| 30.10.2024 14:30 | AZN | IN BRIEF: AstraZeneca China President Leon Wang under investigation | Alliance |
| 30.10.2024 13:00 | AZN | AZN China President under investigation | RNS |
| 28.10.2024 08:46 | AZN | AstraZeneca pleased as EU approves Fasenra for treatment of EGPA | Alliance |
| 21.10.2024 08:35 | AZN | AstraZeneca polyneuropathy treatment recommended for EU approval | Alliance |
| 16.10.2024 09:52 | AZN, HCM | TOP NEWS: AstraZeneca's Tagrisso plus Orpathys shows promising results | Alliance |
| 14.10.2024 10:42 | AZN | TOP NEWS: Enhertu by AstraZeneca, Daiichi wins new approval in China | Alliance |
| 08.10.2024 09:30 | HLN, AZN, BARC | LONDON BROKER RATINGS: Goldman Sachs starts Barclays at 'buy' | Alliance |
| 07.10.2024 10:20 | AZN | AstraZeneca enters agreement to strengthen cardiovascular pipeline | Alliance |
| 07.10.2024 09:30 | AZN | AstraZeneca licenses lipid lowering Lp(a) asset | RNS |
| 07.10.2024 08:52 | AZN | TOP NEWS: AstraZeneca hails Airsupra trial results to treat asthma | Alliance |
| 03.10.2024 11:01 | AZN | TOP NEWS: AstraZeneca's Calquence gets priority review in US | Alliance |
| 03.10.2024 09:39 | SFOR, OMU, MARS | LONDON BROKER RATINGS: Morgan Stanley cuts BAT; boohoo gets buy rating | Alliance |
| 01.10.2024 15:00 | AZN | Total Voting Rights | RNS |
| 01.10.2024 09:39 | AZN | TOP NEWS: AstraZeneca and Daiichi hail Enhertu priority review in US | Alliance |
| 26.09.2024 11:00 | AZN | TOP NEWS: AstraZeneca hails Tagrisso approval in US for cancer form | Alliance |
| 26.09.2024 07:00 | AZN | Tagrisso US approval in unresectable lung cancer | RNS |
| 25.09.2024 13:49 | AZN | Pfizer, Moderna and BioNTech take patent fight to Court of Appeal | Alliance |
| 23.09.2024 08:44 | AZN | TOP NEWS: AstraZeneca cancer drug fails to significantly extend lives | Alliance |
| 23.09.2024 07:05 | AZN | Fasenra recommended for EU approval in EGPA | RNS |
| 23.09.2024 07:00 | AZN | Final OS results reported for TROPION-Breast01 | RNS |
| 20.09.2024 19:08 | AZN | AstraZeneca gets FDA approval for FluMist self-administration | Alliance |
| 20.09.2024 18:00 | AZN | FluMist approved for self-administration in US | RNS |
| 18.09.2024 09:38 | AZN | AstraZeneca Fasenra treatment for EGPA approved in the US | Alliance |
| 18.09.2024 07:00 | AZN | Fasenra EGPA US FDA approval | RNS |
| 16.09.2024 10:05 | AZN | TOP NEWS: AstraZeneca celebrates survival rate of Imfinzi-Imjudo mix | Alliance |
| 13.09.2024 17:00 | AZN | Daiichi, Astra's Enhertu shows clinical activity in brain metastases | Alliance |
| 13.09.2024 09:07 | PAF, ATM, FEVR | LONDON BROKER RATINGS: Deutsche Bank cuts AstraZeneca to 'sell' | Alliance |
| 05.09.2024 11:13 | AZN | China probing AstraZeneca employees for potential illegal acts | Alliance |
| 05.09.2024 10:00 | ECOR, S32, BHP | LONDON BROKER RATINGS: UBS raises Sage Group to 'neutral' | Alliance |
| 02.09.2024 15:00 | AZN | Total Voting Rights | RNS |
| 02.09.2024 12:21 | RESI, MONY, IOM | UK dividends calendar - next 7 days | Alliance |
| 20.08.2024 08:56 | AZN | TOP NEWS: AstraZeneca asthma drug Fasenra gets approval in China | Alliance |
| 19.08.2024 09:31 | AZN | AstraZeneca and Daiichi Sankyo gets US and European nods for Enhertu | Alliance |
| 16.08.2024 08:27 | AZN | AstraZeneca's Infinzi gets US approval for treatment of lung cancer | Alliance |
| 16.08.2024 07:00 | AZN | Imfinzi approved in US for resectable lung cancer | RNS |
| 15.08.2024 08:56 | AZN | TOP NEWS: AstraZeneca's Imfinzi secures US priority review for cancer | Alliance |
| 14.08.2024 09:16 | SHEL, AZN | TOP NEWS: AstraZeneca celebrates EU approval of Lynparza plus Imfinzi | Alliance |
| 13.08.2024 11:38 | AZN | AstraZeneca and Daiichi Sankyo get new approval in China for Enhertu | Alliance |
| 01.08.2024 15:00 | AZN | Total Voting Rights | RNS |
| 01.08.2024 14:32 | VSVS, ULVR, TMI | UK dividends calendar - next 7 days | Alliance |
| 30.07.2024 15:59 | AZN | IN BRIEF: AstraZeneca prices EUR1.4 billion in bonds at 3.1% and 3.3% | Alliance |
| 30.07.2024 07:00 | AZN | AstraZeneca prices a €1.4bn bond offering | RNS |
| 29.07.2024 15:37 | AZN | Astra's breast cancer drug not recommended for NHS use due to price | Alliance |
| 29.07.2024 09:39 | NWG, HSBA, SGRO | LONDON BROKER RATINGS: Citigroup lifts BAE; Morgan Stanley cuts Drax | Alliance |
| 29.07.2024 08:37 | AZN | AstraZeneca reports positive findings from ongoing leukaemia trial | Alliance |
| 26.07.2024 15:27 | AZN, STX, TTG | EXECUTIVE CHANGES: Morgan Advanced Materials picks senior director | Alliance |
| 26.07.2024 13:27 | AZN | IN BRIEF: Astra pushes to get Imfinzi approved for lung cancer in US | Alliance |
| 26.07.2024 09:43 | REL, ULVR, AZN | LONDON BROKER RATINGS: Greencore and Hammerson cut to 'hold' | Alliance |
| 26.07.2024 07:00 | AZN | ODAC reviewed Imfinzi in resectable lung cancer | RNS |
